BCL3 Antikörper
-
- Target Alle BCL3 Antikörper anzeigen
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Detects 55-60 kDa Bcl-3.
- Aufreinigung
- Affinity Chromatography on Protein G.
- Immunogen
- Synthetic peptide surrounding amino acid 424 of human Bcl-3.
- Top Product
- Discover our top product BCL3 Primärantikörper
-
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 300-400) antibody
BCL3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 362-454) antibodyBCL3 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 249-277), (Center) antibodyBCL3 Reaktivität: Human, Maus WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB23954 unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (C-Term) antibodyBCL3 Reaktivität: Human WB, ELISA, IHC, IP, FACS, FM Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 248-277), (Middle Region) antibodyBCL3 Reaktivität: Human, Maus WB, FACS, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 82-341) antibodyBCL3 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 2-13) antibodyBCL3 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 1-446) antibodyBCL3 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 1-446) antibodyBCL3 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 127-376) antibodyBCL3 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot: 2-4 μg/mL. Immunoprecipation: 10-20 μg/mL. Immunohistochemistry: 20-40 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.2 mg/mL
- Buffer
- PBS, pH 7.2, containing 30 % Glycerol, 0.5 % BSA, and 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C/-80 °C
- Informationen zur Lagerung
- Store the antibody undiluted at -20 °C to -70 °C.
-
- Target
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
- Andere Bezeichnung
- Bcl-3 (BCL3 Produkte)
- Synonyme
- BCL3 antikoerper, AI528691 antikoerper, Bcl-3 antikoerper, BCL4 antikoerper, D19S37 antikoerper, B-cell CLL/lymphoma 3 antikoerper, B cell leukemia/lymphoma 3 antikoerper, BCL3 antikoerper, Bcl3 antikoerper
- Hintergrund
- Bcl-3, a proto-oncogene, is believed to be involved in certain human B cell leukemias. It encodes a protein that functions as an IκB-like molecule for native NFκB, but is specific for the p50 subunit of NFκB.Synonyms: B-cell lymphoma 3-encoded protein, BCL3, BCL4, D19S37
- Gen-ID
- 602
- NCBI Accession
- NP_005169
- UniProt
- P20749
- Pathways
- NF-kappaB Signalweg, Maintenance of Protein Location, Protein targeting to Nucleus
-
